Department of Biology, Faculty of Science, University of Sistan and Baluchestan, Zahedan, Iran.
Cellular and Molecular Research Center, Resistant Tuberculosis Institute, Zahedan University of Medical Sciences, Zahedan, Iran.
Endocr Res. 2021 Aug;46(3):129-139. doi: 10.1080/07435800.2021.1914079. Epub 2021 Apr 17.
To investigate the link between two variants (rs4705342 and rs4705343) in the promoter of the cluster with Type 2 diabetes mellitus (T2DM) risk. A total of 1200 subjects were genotyped using the ARMS-PCR method. The rs4705342 variant enhanced the risk of T2DM under codominant CC (OR = 3.24; 95% CI: 1.89-5.60), recessive TT+TC (OR = 3.02; 95% CI: 1.77-5.17), and dominant TC+CC (OR = 1.35; 95% CI: 1.08-1.71) genetic models. Individuals carrying the C allele of rs4705342 conferred a 1.43 fold increased risk of T2DM. As regards rs4705343, decreased risk of T2DM was observed under codominant TC (OR = 0.53; 95% CI: 0.42-0.67), over-dominant TT+CC (OR = 0.51; 95% CI: 0.40-0.64), and dominant TC+CC (OR = 0.59; 95% CI: 0.48-0.75) models. Haplotype analysis of the variants showed a 1.941-fold increased risk of T2DM regarding the C T combination. Significant associations were noticed between different haplotypes and lipid indices of T2DM patients. There were no notable changes in -values after adjustment for BMI. Computational analysis revealed that miR143 and/or miR145 target important genes involved in glucose and lipid metabolism. Functional miR-143/145 variants might influence the risk of T2DM. Hence, clarifying the precise regulatory mechanisms of gene expression in the development of T2DM will significantly guide researchers to find a novel target for therapeutic intervention.
为了探讨 2 型糖尿病(T2DM)风险相关的簇启动子中的两个变体(rs4705342 和 rs4705343)之间的联系。采用 ARMS-PCR 法对 1200 例患者进行基因分型。rs4705342 变体在共显性 CC(OR=3.24;95%CI:1.89-5.60)、隐性 TT+TC(OR=3.02;95%CI:1.77-5.17)和显性 TC+CC(OR=1.35;95%CI:1.08-1.71)遗传模型中增加了 T2DM 的风险。携带 rs4705342 的 C 等位基因的个体 T2DM 的风险增加了 1.43 倍。关于 rs4705343,在共显性 TC(OR=0.53;95%CI:0.42-0.67)、过显性 TT+CC(OR=0.51;95%CI:0.40-0.64)和显性 TC+CC(OR=0.59;95%CI:0.48-0.75)模型中,T2DM 的风险降低。对变体的单体型分析显示,C-T 组合 T2DM 的风险增加了 1.941 倍。不同单体型与 T2DM 患者血脂指数之间存在显著相关性。调整 BMI 后,-值没有明显变化。计算分析表明,miR143 和/或 miR145 靶向参与葡萄糖和脂质代谢的重要基因。功能性 miR-143/145 变体可能影响 T2DM 的风险。因此,阐明基因表达在 T2DM 发生发展中的精确调控机制,将为研究人员寻找治疗干预的新靶点提供重要指导。